The US Food and Drug Administration (FDA) has approved the first generic of Allergan’s Restasis (cyclosporine ophthalmic emulsion) 0.05% single-use eye drops to increase tear production in dry eye patients.
Viatris subsidiary Mylan Pharmaceuticals will manufacture the generic. Viatris president Rajiv Malik said the company had worked for nearly a decade not only to develop a more affordable product but also to remove all barriers to entry and achieve patient access.
New research links glucosamine, a joint pain supplement, to a 25% higher likelihood of progression from mild cognitive impairment (MCI) to
Clinician-scientists identified bacterial pathogens linked to poorest outcomes in postprocedural acute endophthalmitis, potentially supporting faster, personalised treatment and improving patient
EssilorLuxottica and US company Applied Materials have joined forces to accelerate the commercialisation of next-generation intelligent optical systems for augmented reality and AI-powered smart eyewe…
Vanni Eyewear introduces model V1829, an oval frame with a unique nosepiece reinforcement that allows for thick lenses while maintaining lightness and thinness. Available in four colourways.
The Optometric Fees Negotiating Committee (OFNC) is seeking urgent feedback from General Ophthalmic Services (GOS) contractors in England regarding 2026/27 fees and grants, citing
Helping customers understand that sunglasses are not a seasonal indulgence but a year-round necessity for eye health can be tricky on cloudy winter days. But by offering an Rx programme, Bollé and Serengeti, known for their sophisticated, stylish models, are making it easier for eyecare practitioner